Katharine Miller

Spenden & Helfen
 
 

Curriculum vitae

Name Katharine Miller
Place of Birth Wauwatosa, WI, USA
Date of Birth April 5, 1984
   
2011 - present Doctor's thesis about "Molecular biological research of translational control involved in neurological disorders." at the Duncan Laboratory of the University Hospital of Hamburg-Eppendorf, Centre for Molecular Neurobiology Hamburg
2010 - 2011 Worked on the diploma / master's thesis at the University Hospital of Hamburg, Centre for Molecular Neuobiology Hamburg, Thesis: "Molecular biological research of translational control involved in neurological disorders."
2008 Bachelor of Arts, thesis: "Molecular Biology and Genetics" at the Northwestern University in Evanston, Illinois
2006 - 2010 Laboratory technician at the Dallos Laboratory at Northwestern University, School of Communication in Evanston, Illinois, USA
2004-2006 Work study on "Molecular biological research on protein interactions in the outer hair cells of mammalian cochlea" at the Dallos Laboratory at Northwestern University, School of Communication in Evanston, Illinois
2002-2004 Assistance for the collection and organisation of data about the loss of cortisone as a reaction to stress at the Mineka Laboratory at Northwestern University, Weinberg College of Arts and Sciences in Evanston, Illinois
 

Publications

1. CEACAM16 is associated with the Tectorial Membrane and Deafness Locus DFNA4.
Jing Zheng*, Katharine K. Miller*, Tao Yang, P. Kevin Legan, Richard Goodyear, Guy Richardson, MaryAnn Cheatham, Richard J.H. Smith, Peter Dallos. Proc Natl Acad Sci, U.S A. 2011 Mar 8;108(10):4218-23. Epub 2011 Feb 22
*indicates co-first authorship

2. Interaction Between the Motor Protein Prestin and the Transporter Protein Vapa.
Soma Sengupta*, Katharine K. Miller*, MaryAnn Cheatham, Peter Dallos, Jing Zheng. Biochim Biophys Acta, volume 1803 No. 7. pp 796-804. July 2010.
*indicates co-first authorship

3. Interaction between CFTR and Prestin (SLC26A5).
Kazuaki Homma, Katharine K. Miller, Charles T. Anderson, Soma Sengupta, Guo-Guang Du, Salvador Aguinaga, MaryAnn Cheatham, Peter Dallos, Jing Zheng. Biochim Biophys Acta, volume 1798
No. 6. pp. 1029-40. June 2010.

4. EHD4 and CDH23 Are Interacting Partners in Cochlear Hair Cells.
Soma Sengupta, Manju George, Katharine K. Miller, Khurram Naik, Jonathan Chou, MaryAnn Cheatham, Peter Dallos, Mayumi Naramura, Hamid Band, and Jing Zheng. The
Journal of Biological Chemistry, volume 284 No. 30. pp 20121-20129. 24 July 2009

5. Identifying Components of the Hair-Cell Interactome Involved in Cochlear Amplification.
Jing Zheng, Charles T. Anderson, Katharine K. Miller, MaryAnn Cheatham, Peter Dallos. BMC Genomics, 25 March 2009.
 

 

Project Description

TDP-43 and TranslationalControl in FTLD, ALS and Related Neurodegenerative Disorders

Frontotemporal Lobar Degeneration (FTLD) is the second most common cause of presenile onset dementia after Alzheimer’s disease. Recent groundbreaking work supports a major role for the RNA-binding protein (RBP) TDP-43 in FTLD and other major age-related neurological diseases, including Amyotrophic Lateral Sclerosis (ALS) and Alzheimer’s disease. TDP-43 is a ubiquitously expressed, largely nuclear protein in healthy cells. In disease, aberrant localization and aggregation of TDP-43 protein are found in affected neurons 1 and disease-causing mutations in TDP-43 have been identified in both FTLD and ALS patients (reviewed in 2). Nevertheless, how TDP-43 contributes to disease remains unclear.

TDP-43’s relocalization from the nucleus to the cytoplasm in disease affected neurons raises a fundamental, unanswered question: is disease due to a loss of nuclear function, gain of cytoplasmic function, or a combination of the two? Since TDP-43 exhibits nuclear/cytoplasmic shuttling ability, it is likely that TDP-43 has important cytoplasmic functions, as has been described for other nuclear RBPs, such as Sex-lethal 3. Indeed, recent genome-wide studies 4,5 revealed that TDP-43 binding sites are also found in mRNA 3’ UTRs, a key region for cytoplasmic regulation of translation by RBPs. Taken together, available data support the idea that TDP-43 may regulate translation of a subset of mRNAs and suggest that aberrant translational regulation by TDP-43 could play an important role in promoting neurodegeneration and disease.

Here I propose to investigate potential cytoplasmic functions of TDP-43 in mRNA-specific translational control in neurons. In my thesis project I aim specifically to:

  1. Identify mRNAs whose translation is regulated by TDP-43 in neuronal cells
  2. Determine which mRNAs are bona fide in vivo translational targets of TDP-43 in mice
  3. Analyze the translational control mechanism used by TDP-43 on its neuronal targets

To achieve these aims I will use a combination of genome-wide and molecular approaches, many of which I have already previously established during my diploma thesis. By first searching for candidates in neuronal cell culture using polysome profiling, I will be able to easily screen for neuronal mRNA targets and rule out false positives. Subsequent focused studies in mouse will allow validation of specific targets in vivo and exploration of the relevance of targets to disease. Through a combination of cell-based assays and cell-free in vitro translation methods, insight into the underlying molecular mechanism will be obtained.

Through this study, I hope to elucidate TDP-43’s effects on translation of specific neuronal mRNAs. I expect my findings to greatly enhance our understanding of TDP-43’s neuronal functions, both in health and disease. Moreover, this approach has the potential to identify new targets for therapeutic development to treat these devastating diseases.